Exercise and Behavioral Therapy in Obese Children

January 4, 2012 updated by: Nathalie Farpour-Lambert, University Hospital, Geneva

Exercise Training and Family-based Behavioural Treatment in Pre-pubertal Obese Children and Their Mother

The aim of this study is to compare the effects of exercise training and family-based behavioral treatment, either in individual or in group setting, in pre-pubertal children and their mother.

Study Overview

Status

Unknown

Conditions

Detailed Description

Introduction: The prevalence of childhood obesity is increasing rapidly in developing countries. The aim of this study is to determine the effects of exercise training and family-based behavioral treatment (FBBT), either in individual or in group setting,in pre-pubertal children and their mother.

Methods: This is a 6-month randomized controlled trial (RCT) including 75 pre-pubertal obese children (age 8-11 years) randomly assigned to an Intervention (I, n=50) or a Control group (C, n=25). The intervention consists of a family-based behavioural therapy in group (1 session/week with a dietician and a psychologist) or in individual setting (paediatrician or dietician 1x/month). The intervention includes exercise training sessions twice a week (60 minutes each).

Measures include: body mass index (BMI), waist and hip circumferences; whole body and abdominal fat mass by DXA; resting and ambulatory blood pressure; arterial intima-media thickness and vascular reactivity (flow-mediated dilation)using high resolution ultrasound; arterial stiffness by tonometry of applanation; cardiorespiratory fitness by a treadmill test; physical activity; fasting lipids, glucose, insulin, and C-reactive protein levels; health-related quality of life and psychological health using standardized questionnaires and a semi-structured interview. Measures are completed in children and their mother at baseline and 6 months post-randomization.

Study Type

Interventional

Enrollment (Anticipated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1205
        • University Hospital of Geneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Childhood obesity (>97 percentile WHO references)

Exclusion Criteria:

  • being involved in any weight control, physical activity, behavior therapy, or gastric surgery program;
  • familial history of dyslipidemia or essential hypertension;
  • medications or hormones, which may influence cardiovascular function, body composition, lipid or glucose metabolism in the preceding 6 months;
  • orthopaedic affection limiting physical activity;
  • genetic disorder or another chronic disease;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Family-based behavioral therapy
Family-based behavioural therapy either in group or in individual setting. Parents can choose between the 2 types of therapy.
The intervention consist of a 6-month family-based behavioural therapy either in group (1 session/week, with a dietician and a psychologist) or in individual setting (with a paediatrician or a dietician in alternance 1x/month). Both therapies include exercise training twice per week (60 minutes each). Parents, or at at least the mother, must participate to the behavioral treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Body Mass Index at 6 months
Time Frame: 6 months
Body Mass Index (weight/height 2) expressed in Standard Deviation Score
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in total body and abdominal fat at 6 months
Time Frame: 6 months
Body fat mass and percentage assessed using DXA
6 months
Change from baseline in waist circumference at 6 months
Time Frame: 6 months
6 months
Change from baseline in blood pressure at 6 months
Time Frame: 6 months
Resting and ambulatory (24 hours) systolic and diastolic blood pressure
6 months
Change from baseline in arterial intima-media thickness at 6 months
Time Frame: 6 months
Measure of the arterial intima-media thickness using high-resolution ultrasound
6 months
Change from baseline in arterial flow-mediated dilation at 6 months
Time Frame: 6 months
Measure of the flow-mediated dilation of the brachial artery using high-resolution ultrasound
6 months
Change from baseline in arterial stiffness at 6 months
Time Frame: 6 months
Measure of mechanical indices using tonometry of applanation
6 months
Change from baseline in cardiorespiratory fitness at 6 months
Time Frame: 6 months
6 months
Change from baseline in physical activity at 6 months
Time Frame: 6 months
Physical activity pattern using accelerometer
6 months
Change from baseline in biological markers at 6 months
Time Frame: 6 months
Fasting glucose, insulin, total-, LDL-, HDL-cholesterol, high-sensitive C-reactive protein.
6 months
Change from baseline in quality of life at 6 months
Time Frame: 6 months
Quality of life assessed using the Kidsscreen 52 questionnaire
6 months
Change from baseline in child's behavior at 6 months
Time Frame: 6 months
Child Behavior Checklist filled by parents
6 months
Change from baseline in parental psychological health at 6 months
Time Frame: 6 months
Global Health Questionnaire filled by parents
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nathalie Farpour-Lambert, MD, University of Geneva

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Anticipated)

June 1, 2012

Study Completion (Anticipated)

December 1, 2012

Study Registration Dates

First Submitted

December 31, 2011

First Submitted That Met QC Criteria

January 4, 2012

First Posted (Estimate)

January 9, 2012

Study Record Updates

Last Update Posted (Estimate)

January 9, 2012

Last Update Submitted That Met QC Criteria

January 4, 2012

Last Verified

January 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • SNF 3200B0-120437

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Obesity

Clinical Trials on Family-based behavioral therapy

3
Subscribe